Key facts
- It has raised $24.1M across 3 recorded rounds; the latest was Early Stage VC ($6.5M) in Feb 2024.
- Notable investors include Triangle Tweener Fund, Emil Capital Partners, 550 Capital Partners, Consumer Ventures, FreshTracks Capital — 10 tracked in total.
- Murphy's Naturals has filed 4 Form Ds with the SEC since 2019, most recently Mar 2024 ($6.5M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Murphy's Naturals
Funding rounds
3 roundsAbout Murphy's Naturals
Manufacturer of natural insect repellant products intended to keep insects away. The company's products help in removing or repelling mosquitoes and other insects that can be harmful to humans and pets and are made from responsibly sourced plant-based ingredients, enabling customers to use earth-friendly products that shield them from insects and bug bites.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Raleigh, NC, United States
- Founded
- 2013
- Employees
- 36
- Website
- murphysnaturals.com/
- Ownership
- Privately Held (backing)
Murphy's Naturals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Murphy's Naturals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Murphy's Naturals in its N-PORT filings yet. We sweep new filings monthly.